JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Dopamine Receptor

B3248 Vanoxerine dihydrochloride
1 Citation

Summary: potent and selective DRI (Dopamine reuptake inhibitor)

insoluble in EtOH; ≥15.4 mg/mL
B2235 Clozapine

Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|D4 Receptors

Summary: 5-HT receptor antagonist

insoluble in H2O; ≥14.95 mg/mL
B2232 Aripiprazole

Target: 5-HT1 Receptors

Summary: 5-HT receptor partial agonist

≥22.4 mg/mL
B2099 Haloperidol

Summary: Antipsychotic drug

insoluble in H2O; ≥18.79 mg/mL
B2075 Ambrisentan

Target: ETA Receptors

Summary: ETA-receptor antagonist

insoluble in H2O; ≥18.92 mg/mL
B1626 LY404039

Summary: MGlu2 and mGlu3 receptors agonist

insoluble in DMSO; insoluble in EtOH; insoluble in H2O
B1522 Sitaxentan sodium

Summary: Selective endothelin A receptor (ETA) antagonist

≥23.84 mg/mL
B1490 Quetiapine Fumarate
1 Citation

Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 Receptors

Summary: Dopamine receptor antagonist

insoluble in H2O; insoluble in EtOH; ≥11.03 mg/mL
B1488 Pramipexole

Target: D2 Receptors|D3 Receptors|D4 Receptors

Summary: Dopamine agonist

insoluble in H2O; ≥10.57 mg/mL
B1487 Pramipexole 2HCl Monohydrate

Summary: Novel non-ergoline dopamine receptor agonist

≥15.11 mg/mL